Project Grant K99GM166787
Award Date 9/3/26
Completion Date 7/31/28
Dollars Obligated $113K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
- The National Institute of General Medical Sciences awarded the University of Illinois $380,350 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to systematically characterize human disease-associated protein complexes. The recipient will develop machine learning approaches to identify biologically relevant protein complex variants from over 32,000 mass spectrometry experiments, construct cell-type-specific protein complex maps focusing on early embryonic...
- The National Institute of General Medical Sciences awarded the University of Illinois $303,685 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to discover and characterize RIPP biosynthetic enzymes. The work focuses on assigning catalytic function to domains of unknown function (DUFs) encoded in microbial genomes, particularly those involved in ribosomally synthesized and posttranslationally modified peptides (RIPPs) biosynthesis. The research...
- The National Institute of General Medical Sciences awarded the University of Illinois $2,101,232 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop quantitative computational approaches that probe diverse biological processes and relate their outcomes to molecular structure and motion. The project will develop computational methods ranging from atomistic molecular dynamics to continuum simulations, guided by unmet needs in basic biomedical...
- The National Institute of General Medical Sciences awarded the University of Illinois $395,194 on July 21, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop interpretable machine learning models for decoding cellular dynamics in single-cell and spatial omics datasets. The project will design multimodal machine learning approaches that integrate transcriptomics, imaging data, and text-based knowledge to disentangle gene programs and cellular factors that...
- The National Institute of General Medical Sciences, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $614,467 on April 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to develop switchable artificial metalloproteins (SWARMs) that model conformational control in metalloenzyme reactivity. The research, led by principal investigator Lisa Olshansky, combines synthetically prepared metal...
- The National Institute of General Medical Sciences awarded the University of Illinois $1,385,652 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop in vivo metabolic tagging and targeting of long-circulating red blood cell biomembranes. The project aims to create a platform technology for metabolic tagging of red blood cell (RBC) membranes using unnatural sugars and subsequent targeting of molecular imaging and therapeutic cargo via click...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services, awarded the University of Illinois $526,483 on May 14, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop enhanced epigenome editing technologies for controlling mammalian gene expression. The award funds development of a toolkit of programmable epigenome editors capable of activating gene expression in vivo through three integrated aims. Aim 1...
- The National Institute of General Medical Sciences awarded The University of Chicago $1,725,379 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing R01GM166338) to develop spatially-informed artificial intelligence tools that jointly analyze single-cell RNA-sequencing and spatial transcriptomics data to infer and quantify niche-dependent cell-state transitions in tissue contexts. The project delivers inference methods for spatial...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded the University of Illinois $757,625 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) for the development of multiplexed connectomic mapping methods for brain microcircuits. The funded work will develop an integrated platform combining computational design of epitope-defined affinity binders for cell-type identification, electron microscopy-compatible...
- The National Institute of General Medical Sciences awarded the University of Illinois $372,016 on July 7, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to deconstruct RNA polymerase III regulation and function through systematic profiling of POL III activity and discovery of new regulatory mechanisms. The research applies genomic and biochemical strategies to characterize POL III transcription breadth and tissue-specific patterns, focusing initially on the...
The National Institute of General Medical Sciences awarded the University of Illinois $113,211 on September 3, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop mass spectrometry-based instrumentation and computational tools for spatiotemporal neuropeptidomics with isomer-resolved capabilities. The work will map neuropeptide distribution and release with high spatial and temporal resolution and increased throughput, creating new molecular signatures of neuropeptide signaling and broadly applicable strategies for their detection, monitoring, and therapeutic targeting. Performance occurs in Urbana, Illinois, with a period of performance through July 31, 2028.
Generated 9/8/26, 5:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $113.2k | 9/3/26 |